Medicis Pharmaceutical Aktie

Medicis Pharmaceutical für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN: 881835 / ISIN: US5846903095

<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
08.10.2025 13:48:34

Marex Group Preliminary Q3 Results Climb

(RTTNews) - Marex Group PLC (MRX), a financial services provider, on Wednesday reported a rise in preliminary earnings and revenue for the third quarter.

For the three-month period to September 30, the company expects a net income of $70 million to $73 million, or $0.88 per share to $0.93 per share.

For the third quarter of 2024, the company had recorded a net profit of $58 million, or $0.73 per share.

Excluding items, income is anticipated to be $69 million to $73 million, or $0.92 to $0.97 per share.

For the third quarter of 2024, the Group had posted an adjusted profit of $58 million, or $0.76 per share.

Marex Group projects revenue of $475 million to $485 million, up from last year's $391 million.

On average, analysts polled forecast the company to earn $0.91 per share on revenue of $475.36 million for the quarter. Analysts' estimates typically exclude special items.

MRX was up by 2.34% at $28.90 in the pre-market trade on the Nasdaq.

Nachrichten zu Medicis Pharmaceutical Corp.mehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Medicis Pharmaceutical Corp.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!